Toggle navigation
Home
Search
Services
Blog
Contact
About
Directed Mutagenesis of Htlv-III
Potz, Joseph L.
Dana-Farber Cancer Institute, Boston, MA, United States
Search grants from Joseph Potz
Search grants from Dana-Farber Cancer Institute
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Dynamic Aspects of Olfactory Signal Transduction
Research Initiative for Scientific Enhancement at CSULB
Gonococcal 44,000 Dalton Protein
Receptor Regulation of CA in Vascular Smooth Muscle
Maintain Tumor Bearing Laboratory Animal Models
Recently added grants:
2/2 Rare Genetic Variation and Risk for Obsessive Compulsive Disorder
The regulation and function of long non coding RNA in ischemic AKI: Role of GSTM3P1
Immune-based therapy against STEC intoxication and HUS
Understanding the reciprocal regulation between Hsp70 and the DNA damage response
Novel strategies to understand, predict, and prevent vascular toxicity of targeted CML therapies
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32AI007502-02
Application #
3029394
Study Section
Clinical Sciences Subcommittee 1 (CLN)
Project Start
1987-04-01
Project End
Budget Start
1987-04-01
Budget End
1987-06-30
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 1987
F32 AI
Directed Mutagenesis of Htlv-III
Potz, Joseph L. / Dana-Farber Cancer Institute
NIH 1986
F32 AI
Directed Mutagenesis of Htlv-III
Potz, Joseph L. / Dana-Farber Cancer Institute
Comments
Be the first to comment on Joseph Potz's grant